Egeli 2004.
Methods | Design: double‐blind, prospective randomized controlled trial Country: Turkey Multisite: no International: no Treatment duration: postoperative period Follow‐up: 1 week postoperatively Operative procedure(s): adenotonsillectomy Randomization unit: participants Analysis unit: individual | |
Participants |
Exclusion criteria included:
Randomized to:
Main characteristics of participants:
|
|
Interventions |
Co‐interventions: none stated |
|
Outcomes |
|
|
Notes | Trial registration: not stated Funder: not stated A priori sample size estimation: not stated Conducted: dates not stated Declared conflicts of interest: not stated | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No information on the randomization protocol was provided. |
Allocation concealment (selection bias) | Unclear risk | No information on the randomization protocol was provided. |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants and their parents were aware of group allocation as the intervention was postoperative IV fluid administration. |
Blinding of outcome assessment (detection bias) All outcomes | High risk | The (unblinded) parent completed the questionnaire and used the McGrath Face Scale to assess pain. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No withdrawals were stated. |
Selective reporting (reporting bias) | Low risk | All outcomes were reported. |
Other bias | Low risk | There were no other sources of bias. |